Axis Pension Fund has introduced 'NPS Swasthya,' a hybrid retirement solution that integrates long-term savings with a mandatory super top-up health insurance policy. The scheme allows subscribers to earmark up to 25% of their pension contributions for a market-linked medical emergency corpus, offering a buffer against rising healthcare costs. Investors should note that the health cover functions as a super top-up, meaning standard insurance deductibles and policy terms still apply.
On NPS Diwas, marked on October 1, 2026, Axis Pension Fund Management launched 'NPS Swasthya,' a new pension-linked healthcare initiative developed under the guidelines of the Pension Fund Regulatory and Development Authority (PFRDA). This scheme is designed to address the liquidity challenges often faced by retirees when managing unexpected medical expenses, allowing for a structured approach to funding both retirement and health needs.
How the Hybrid Structure Works
NPS Swasthya is not a standalone insurance product; it operates as a dual-component model. It pairs a dedicated National Pension System (NPS) investment account with a mandatory super top-up health insurance policy. Subscribers are required to contribute to both. The primary innovation is the ability to earmark up to 25% of the contributions made to the NPS Swasthya account for medical expenses. Unlike traditional retirement funds that are largely locked until the age of 60, this earmarked corpus provides a degree of flexibility for defined medical emergencies.
Importantly, the healthcare component is provided as a super top-up policy. This means it is designed to cover eligible expenses that exceed a certain 'deductible' limit. Investors should be aware that this does not replace a primary, comprehensive health insurance policy. The coverage is subject to the terms, conditions, and deductibles set by the insurer, and the scheme is intended to complement, rather than substitute, standard medical insurance.
Strategic and Investor Considerations
For investors, the scheme offers a way to build a secondary medical fund that grows with market-linked returns. Since the funds remain invested in the pension account, they have the potential to grow over the long term if they are not used immediately for medical needs. However, the benefits are subject to the performance of the chosen investment pattern, which follows the Central Government Scheme guidelines under PFRDA regulations.
From a financial planning perspective, the scheme introduces a practical solution for managing 'out-of-pocket' medical costs, which are often not fully covered by basic insurance policies. However, the dependency on market returns for the medical corpus means that in periods of market volatility, the value of the medical emergency fund may fluctuate.
Axis Pension Fund Management, the entity behind this product, is a subsidiary of Axis Bank. Investors should note that the pension fund entity itself is unlisted, and this product is a service offering aimed at broadening the utility of the NPS framework. As with any long-term retirement and health product, the effectiveness of NPS Swasthya will depend on individual contribution consistency, the chosen investment allocation, and the specific terms of the super top-up insurance cover provided at the time of enrollment. Potential subscribers should review the policy wording carefully, specifically regarding what constitutes an 'eligible' medical expense and how the claims process for the super top-up component integrates with the NPS account withdrawal.